Diseases Produced by Clostridium spiroforme

J. Glenn Songer, Francisco A Uzal

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Several clostridial species, including Clostridium perfringens, Clostridium difficile, and Clostridium spiroforme, affect the intestinal tract of rabbits. This chapter describes enteric disease produced by C. spiroforme, which is considered the most prevalent clostridial pathogen responsible for rabbit enteric disease, particularly in young animals. C. spiroforme is acquired by the fecal-oral route and colonizes the terminal small intestine and cecum, where it produces C. spiroforme toxin (CST), which is considered to be the main virulence factor of this microorganism. Antibiotic treatment should include narrow-spectrum orally administered antibiotics with activity against Gram-positive antibiotics; examples include penicillin and ampicillin, although macrolide and lincosamide activity is poor. Probiotics are frequently used in the treatment of gastrointestinal diseases of rabbits based largely on anecdotal evidence of a beneficial effect rather than on scientific study. Little work has been performed to understand the basis of immunity to C. spiroforme infection and develop effective immunization strategies.

Original languageEnglish (US)
Title of host publicationClostridial Diseases in Animals
Publisherwiley
Pages221-227
Number of pages7
ISBN (Electronic)9781118728291
ISBN (Print)9781118728406
DOIs
StatePublished - Apr 8 2016

Fingerprint

Clostridium spiroforme
Clostridium
Anti-Bacterial Agents
Rabbits
digestive system diseases
Lincosamides
antibiotics
rabbits
Clostridium perfringens
Clostridium difficile
Cecum
Gastrointestinal Diseases
Macrolides
Probiotics
Virulence Factors
Ampicillin
Penicillins
Small Intestine
Immunity
Immunization

Keywords

  • C. spiroforme toxin
  • Clostridium spiroforme
  • Enteric disease
  • Gastrointestinal diseases
  • Probiotics
  • Rabbit
  • Virulence factor

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Songer, J. G., & Uzal, F. A. (2016). Diseases Produced by Clostridium spiroforme. In Clostridial Diseases in Animals (pp. 221-227). wiley. https://doi.org/10.1002/9781118728291.ch18

Diseases Produced by Clostridium spiroforme. / Songer, J. Glenn; Uzal, Francisco A.

Clostridial Diseases in Animals. wiley, 2016. p. 221-227.

Research output: Chapter in Book/Report/Conference proceedingChapter

Songer, JG & Uzal, FA 2016, Diseases Produced by Clostridium spiroforme. in Clostridial Diseases in Animals. wiley, pp. 221-227. https://doi.org/10.1002/9781118728291.ch18
Songer JG, Uzal FA. Diseases Produced by Clostridium spiroforme. In Clostridial Diseases in Animals. wiley. 2016. p. 221-227 https://doi.org/10.1002/9781118728291.ch18
Songer, J. Glenn ; Uzal, Francisco A. / Diseases Produced by Clostridium spiroforme. Clostridial Diseases in Animals. wiley, 2016. pp. 221-227
@inbook{729d071713c644b5a2d870cfd4e4b887,
title = "Diseases Produced by Clostridium spiroforme",
abstract = "Several clostridial species, including Clostridium perfringens, Clostridium difficile, and Clostridium spiroforme, affect the intestinal tract of rabbits. This chapter describes enteric disease produced by C. spiroforme, which is considered the most prevalent clostridial pathogen responsible for rabbit enteric disease, particularly in young animals. C. spiroforme is acquired by the fecal-oral route and colonizes the terminal small intestine and cecum, where it produces C. spiroforme toxin (CST), which is considered to be the main virulence factor of this microorganism. Antibiotic treatment should include narrow-spectrum orally administered antibiotics with activity against Gram-positive antibiotics; examples include penicillin and ampicillin, although macrolide and lincosamide activity is poor. Probiotics are frequently used in the treatment of gastrointestinal diseases of rabbits based largely on anecdotal evidence of a beneficial effect rather than on scientific study. Little work has been performed to understand the basis of immunity to C. spiroforme infection and develop effective immunization strategies.",
keywords = "C. spiroforme toxin, Clostridium spiroforme, Enteric disease, Gastrointestinal diseases, Probiotics, Rabbit, Virulence factor",
author = "Songer, {J. Glenn} and Uzal, {Francisco A}",
year = "2016",
month = "4",
day = "8",
doi = "10.1002/9781118728291.ch18",
language = "English (US)",
isbn = "9781118728406",
pages = "221--227",
booktitle = "Clostridial Diseases in Animals",
publisher = "wiley",

}

TY - CHAP

T1 - Diseases Produced by Clostridium spiroforme

AU - Songer, J. Glenn

AU - Uzal, Francisco A

PY - 2016/4/8

Y1 - 2016/4/8

N2 - Several clostridial species, including Clostridium perfringens, Clostridium difficile, and Clostridium spiroforme, affect the intestinal tract of rabbits. This chapter describes enteric disease produced by C. spiroforme, which is considered the most prevalent clostridial pathogen responsible for rabbit enteric disease, particularly in young animals. C. spiroforme is acquired by the fecal-oral route and colonizes the terminal small intestine and cecum, where it produces C. spiroforme toxin (CST), which is considered to be the main virulence factor of this microorganism. Antibiotic treatment should include narrow-spectrum orally administered antibiotics with activity against Gram-positive antibiotics; examples include penicillin and ampicillin, although macrolide and lincosamide activity is poor. Probiotics are frequently used in the treatment of gastrointestinal diseases of rabbits based largely on anecdotal evidence of a beneficial effect rather than on scientific study. Little work has been performed to understand the basis of immunity to C. spiroforme infection and develop effective immunization strategies.

AB - Several clostridial species, including Clostridium perfringens, Clostridium difficile, and Clostridium spiroforme, affect the intestinal tract of rabbits. This chapter describes enteric disease produced by C. spiroforme, which is considered the most prevalent clostridial pathogen responsible for rabbit enteric disease, particularly in young animals. C. spiroforme is acquired by the fecal-oral route and colonizes the terminal small intestine and cecum, where it produces C. spiroforme toxin (CST), which is considered to be the main virulence factor of this microorganism. Antibiotic treatment should include narrow-spectrum orally administered antibiotics with activity against Gram-positive antibiotics; examples include penicillin and ampicillin, although macrolide and lincosamide activity is poor. Probiotics are frequently used in the treatment of gastrointestinal diseases of rabbits based largely on anecdotal evidence of a beneficial effect rather than on scientific study. Little work has been performed to understand the basis of immunity to C. spiroforme infection and develop effective immunization strategies.

KW - C. spiroforme toxin

KW - Clostridium spiroforme

KW - Enteric disease

KW - Gastrointestinal diseases

KW - Probiotics

KW - Rabbit

KW - Virulence factor

UR - http://www.scopus.com/inward/record.url?scp=85024852928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024852928&partnerID=8YFLogxK

U2 - 10.1002/9781118728291.ch18

DO - 10.1002/9781118728291.ch18

M3 - Chapter

AN - SCOPUS:85024852928

SN - 9781118728406

SP - 221

EP - 227

BT - Clostridial Diseases in Animals

PB - wiley

ER -